Showing 581-590 of 2792 results for "".
Optimizing FcRn Therapy: Addressing and Reducing Adverse Reactions
https://practicalneurology.com/programs/cme/optimizing-fcrn-therapy-addressing-and-reducing-adverse-reactions/32243/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.The Science Behind FcRn Antagonists: A Deep Dive Into Their Mechanism of Action
https://practicalneurology.com/programs/cme/the-science-behind-fcrn-antagonists-a-deep-dive-into-their-mechanism-of-action/32241/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.Balancing Risk and Benefit: Traditional MG Treatments and Medications to Avoid
https://practicalneurology.com/programs/cme/balancing-risk-and-benefit-traditional-mg-treatments-and-medications-to-avoid/32240/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.Toward Personalized Care for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/toward-personalized-care-for-multiple-sclerosis/31754/Biomarkers and precision medicine are just part of individualizing care for a diverse population of people with multiple sclerosis.Multiple Sclerosis in the Black Population of the United States
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-in-the-black-population-of-the-united-states/31756/Black people with multiple sclerosis are affected by frequent relapses, early disability accrual, and rapid disease progression.Sphingosine-1-Phosphate Modulators for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/sphingosine-1-phosphate-modulators-for-multiple-sclerosis/31629/Sphingosine-1-phosphate modulators may act through more than just inhibition of neuroimmune and neuroinflammatory effects of multiple sclerosis.Nonpharmacologic Approaches to Adverse Behaviors Associated with Dementia
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/nonpharmacologic-approaches-to-adverse-behaviors-associated-with-dementia/32015/Commonsense approaches to frequently occurring dementia-related adverse behaviors.COVID-19 & Stroke
https://practicalneurology.com/diseases-diagnoses/stroke/covid-19-stroke/31740/COVID-19 has brought significant changes in stroke presentations, systems of care, and resource availability.Headache Horizons: The Study and Use of Psychedelics in Cluster Headache
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-horizons-the-study-and-use-of-psychedelics-in-cluster-headache/32032/Psychedelics have a history of use in headache disorders and evidence exists for their therapeutic benefit in cluster headache.Migraine Associated Vertigo: A Common but Difficult-to-Define Disorder
https://practicalneurology.com/diseases-diagnoses/headache-pain/PN0909_02-php/30888/A specialist reviews the clinical features and differential diagnosis of this potentially under-recognized phenomenon.